InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Satvat Ali J.. Officer active across 2 companies, notably BridgeBio Pharma, Inc.. Aggregated, 6 reports have been published. History available since 30 December 2024. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Satvat Ali J. is a declarant linked to BridgeBio Pharma, Inc. and Coherus Oncology, Inc., where the listed role is Director. The record shows 6 filings in total, and the sampled filings run from 2024-12-31 to 2026-06-24. The sampled transactions are of Attribution nature, with top filing amounts of EUR 1001492.854589783, EUR 839863.1416971934, and EUR 637348.3714062414.